Literature DB >> 11933257

Methylenetetrahydrofolate reductase: a common human polymorphism and its biochemical implications.

Rowena G Matthews1.   

Abstract

Methlenetetrahydrofolate (CH2-H4folate) is required for the conversion of homocysteine to methionine and of dUMP to dTMP in support of DNA synthesis, and also serves as a major source of one carbon unit for purine biosynthesis. This review presents biochemical studies of a human polymorphism in methylenetetrahydrofolate reductase, which catalyzes the reaction shown below. The mutation decreases the flux of CH2-H4folate into CH3-H4folate, and is associated with both beneficial and deleterious effects that can be traced to the molecular effect of the substitution of alanine 222 by valine. Copyright 2002 The Japan Chemical Journal Forum and John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11933257     DOI: 10.1002/tcr.10006

Source DB:  PubMed          Journal:  Chem Rec        ISSN: 1528-0691            Impact factor:   6.771


  10 in total

1.  Folic acid and its congeners in the treatment of schizophrenia.

Authors:  Jacob Peedicayil
Journal:  Psychopharmacology (Berl)       Date:  2018-10-31       Impact factor: 4.530

Review 2.  Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.

Authors:  J R Miranda-Massari; M J Gonzalez; F J Jimenez; M Z Allende-Vigo; J Duconge
Journal:  Curr Clin Pharmacol       Date:  2011-11

3.  Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy.

Authors:  Francisco J Jiménez-Ramírez; Liza M Castro; Clarymar Ortiz; Jennifer Concepción; Jessicca Y Renta; Raúl H Morales-Borges; Jorge R Miranda-Massari; Jorge Duconge
Journal:  Drug Metab Pers Ther       Date:  2017-03-01

4.  Functional role for the conformationally mobile phenylalanine 223 in the reaction of methylenetetrahydrofolate reductase from Escherichia coli.

Authors:  Moon N Lee; Desire Takawira; Andriana P Nikolova; David P Ballou; Vivek C Furtado; Ngoc L Phung; Brady R Still; Melissa K Thorstad; John J Tanner; Elizabeth E Trimmer
Journal:  Biochemistry       Date:  2009-08-18       Impact factor: 3.162

5.  Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis.

Authors:  L K Wei; S Menon; L R Griffiths; S H Gan
Journal:  J Hum Hypertens       Date:  2014-07-24       Impact factor: 3.012

6.  Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.

Authors:  Vicki L Ellingrod; Del D Miller; Stephan F Taylor; Jessica Moline; Timothy Holman; Jane Kerr
Journal:  Schizophr Res       Date:  2007-10-31       Impact factor: 4.939

7.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

8.  Additive effect of MTHFR and GRIN1 genetic polymorphisms on the risk of schizophrenia.

Authors:  Ali Mohammad Foroughmand; Hamid Galehdari; Atefeh Pooryasin; Tahereh Ajam; Seyed Reza Kazemi-Nezhad
Journal:  Mol Biol Res Commun       Date:  2015-01

9.  MTHFR Gene Mutations Correlate with White Matter Disease Burden and Predict Cerebrovascular Disease and Dementia.

Authors:  Christian E Cajavilca; Rajan R Gadhia; Gustavo C Román
Journal:  Brain Sci       Date:  2019-08-22

10.  Methylene tetrahydrofolate reductase gene mutation in sickle cell anaemia patients in Lagos, Nigeria.

Authors:  Oluwaseun Olabisi Adelekan; Ebele Ifeyinwa Uche; Taiwo Modupe Balogun; Vincent Oluseye Osunkalu; Akinsegun Abduljaleel Akinbami; Kamal Ayobami Ismail; Mulikat Adesola Badiru; Adedoyin Owolabi Dosunmu; Omolara Risqat Kamson
Journal:  Pan Afr Med J       Date:  2019-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.